Consequently, the overexpression of ABCG2 found in many human cancers is thought to be a major contributor to the development of multidrug resistance (MDR), which is a serious obstacle in cancer treatment (Fletcher et al., 2016; Robey et al., 2018). Here, ABCG2 is linked to cancer.